Manufacturers Life Insurance Company, The Arbutus Biopharma Corp Transaction History

Manufacturers Life Insurance Company, The

$103 Billion
Q1 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 53,132 shares of ABUS stock, worth $167,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,132

Previous 52,167 1.85%

Holding current value

$167,897

Previous $130,000 5.38%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.26 - $2.92 $2,180 - $2,817	965 Added 1.85%	53,132 $137,000
Q2 2023 Aug 11, 2023	BUY	$2.24 - $3.06 $22,413 - $30,618	10,006 Added 23.73%	52,167 $119,000
Q4 2022 Aug 11, 2023	BUY	$1.91 - $2.85 $320 - $478	168 Added 0.4%	42,161 $98,000
Q4 2022 Feb 13, 2023	BUY	$1.91 - $2.85 $320 - $478	168 Added 0.4%	42,161 $98,000
Q3 2022 Aug 11, 2023	SELL	$1.88 - $2.88 $3,233 - $4,953	-1,720 Reduced 3.93%	41,993 $80,000

Q3 2022 Nov 03, 2022	SELL	$1.88 - $2.88 $3,233 - $4,953	-1,720 Reduced 3.93%	41,993 $80,000
Q2 2022 Aug 11, 2023	BUY	$1.98 - $3.17 $15,105 - $24,183	7,629 Added 21.14%	43,713 $118,000
Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $15,105 - $24,183	7,629 Added 21.14%	43,713 $118,000
Q1 2022 Aug 11, 2023	SELL	$2.42 - $3.98 $14,706 - $24,186	-6,077 Reduced 14.41%	36,084 $107,000
Q1 2022 May 20, 2022	SELL	$2.42 - $3.98 $16,700 - $27,465	-6,901 Reduced 16.05%	36,084 $108,000
Q4 2021 Feb 16, 2022	SELL	$3.11 - $4.61 $10,011 - $14,839	-3,219 Reduced 6.97%	42,985 $167,000
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $7,051 - $12,293	-2,661 Reduced 5.45%	46,204 $198,000
Q2 2021 Aug 12, 2021	BUY	$2.5 - $3.51 $122,162 - $171,516	48,865 New	48,865 $148,000
Q2 2019 Aug 14, 2019	SELL	$1.46 - $4.44 $38,234 - $116,274	-26,188 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.41 - $4.57 $52,159 - $69,902	15,296 Added 140.43%	26,188 $93,000
Q4 2018 Feb 14, 2019	SELL	$3.5 - $9.66 $44,149 - $121,851	-12,614 Reduced 53.66%	10,892 $42,000
Q3 2018 Nov 14, 2018	SELL	$7.85 - $12.35 $50,161 - $78,916	-6,390 Reduced 21.37%	23,506 $223,000
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $149,480 - $219,735	29,896 New	29,896 $218,000

Others Institutions Holding ABUS

# of Institutions

130

Shares Held

82.2M

Call Options Held

4.82M

Put Options Held

546K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $474M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Arbutus Biopharma Corp Transaction History